Home Newsletters Cancer Stem Cell News CHK1 Inhibitor Sensitizes Resistant Colorectal Cancer Stem Cells to Nortopsentin

CHK1 Inhibitor Sensitizes Resistant Colorectal Cancer Stem Cells to Nortopsentin

0
Scientists reported that exposure to a neo-synthetic bis(indolyl)thiazole alkaloid analogue, Nortopsentin 234, led to an initial reduction of proliferative and clonogenic potential of colorectal cancer sphere cells (CR-CSphCs), followed by an adaptive response selecting the CR-CSphCs resistant compartment.
[iScience]
6445212 RCTWUBXZ items 1 apa 0 default asc 1 162828 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full ArticleGraphical Abstract
Exit mobile version